FDA Leaders Dish On Agency Policies Under Trump

Law360, Washington (May 5, 2017, 7:38 PM EDT) -- U.S. Food and Drug Administration leaders, as well as experts from Big Pharma and BigLaw, took the stage at a major annual conference and shared wide-ranging perspectives on the agency’s likely priorities and policies under the Trump administration.

The conference drew hundreds of attorneys on Thursday and Friday to the Ronald Reagan Building and International Trade Center in Washington, D.C.

Here are four key takeaways from Thursday's sessions at the Food and Drug Law Institute’s annual gathering.

FDA Will Stay 'Fresh,' Ostroff Says

Stephen Ostroff, the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.